Skip the navigation buttons.
Home
Scientific Programme
Call for Abstracts
Presentation Guidelines
Registration
Accommodation
Social Events
Exhibition and Sponsorship
Press Centre
General Information
Downloads
Useful links
Dates to remember
Contact
ECTS Home Page
 

See/download the Final Announcement!

Exhibition Catalogue

Exhibition Layout

Exhibition opening times

Sunday 6 May 09:30 - 17:30
Monday 7 May 09:30 - 17:30
Tuesday 8 May 09:30 - 17:30
Wednesday 9 May 09:30 - 12:00


STAND 7
The Alliance for Better Bone Health

Procter & Gamble Pharmaceuticals and sanofi-aventis
Website: www.pg.com and www.sanofi-aventis.com

Procter & Gamble Pharmaceuticals and sanofi-aventis invite you to our exhibit to learn the latest information on Actonel® (risedronate sodium tablets).


STAND L1
American Society for Bone and Mineral Research (ASBMR)

2025 M St, NW, Suite 800, Washington, DC 20036 USA
Website: www.asbmr.org

The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists involved in the study of bone and mineral metabolism. ASBMR encourages and promotes the study of this expanding field through annual scientific meetings, an official journal (Journal of Bone and Mineral Research), the Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, advocacy and interaction with government agencies and related societies.


STAND 10
Amgen

Dammstr 23, 6300 Zug, Switzerland
Website: www.amgen.com

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, please visit our booth.


STAND 12
Biomedica

Divischgasse 4, 1210 Wien, Austria
Website: www.bmgrp.com

Biomedica Gruppe, an ISO 9001:2000 certified company, is a privately owned group of companies with head-quarters in Vienna (Austria).

Our field of action comprises the distribution of medical devices, focussed on in vitro diagnostics and biochemical reagents, nephrology and intensive care, cardiology, cardiac surgery and the research and development as well as production of innovative immunoassays for cardiovascular investigations (BNP, ANP, Big / ET, MGP) and bone metabolism (OPG, sRANKL, Cathepsin K, NT-proCNP).

Two new ELISA kits will enlarge our Bone product line in 2007: Ampli-sRANKL ELISA


STAND 3
Eli Lilly and Company

Lilly Corporate Center, Indianapolis, Indiana 46285 United States
Website: www.lilly.com

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com


STAND L4
European Calcified Tissue Society

PO Box 337, Bristol BS32 4ZR, UK
Website: www.ectsoc.org

The European Calcified Tissue Society (ECTS) is the major organisation in Europe for researchers and clinicians working in the field of calcified tissues and related fields. The Society acts as a forum for the dissemination of high quality research through its annual meeting and workshops. Benefits of membership include reduced subscription to the journals Calcified Tissue International and Osteoporosis International. The ECTS provides various grants and awards including the Career Establishment Award, ECTS/Amgen Bone Biology Fellowship, the Alliance for Better Bone Health Iain Boyle Award, ECTS Exchange Grants and ECTS Travel and Young Investigator Awards. Full details on criteria and application procedures are available from the ECTS website at www.ectsoc.org. Membership is open to anyone working in the field at whatever stage in their career and from anywhere in the world.


STAND 8 & 9
GE Healthcare - Lunar Densitometry

GE Medical Systems Benelux NV/SA, Kouterveldstraat 20, B-1831 Diegem, Belgium
Website: www.gehealthcare.com

Lunar Densitometry, the #1 densitometry equipment partner world-wide, delivers annual breakthroughs enabling a wide spectrum of specialty clinicians and researchers to assess Bone Health and Beyond.
On our ECTS7 booth (n° 8 & 9) you will find out all you want to know about the Lunar Densitometry portfolio and it’s clinical and research application.
Lunar Densitometry - Dedicated to Bone Health and Beyond


STAND 17
Hologic

35 Crosby Drive, Bedford, MA 01730
Website: www.hologic.com

Hologic showcases the Discovery bone densitometer. Discovery bone densitometers quickly and precisely measures the two primary diagnostic indicators of osteoporosis - bone mineral density and vertebral fractures. At ECTS, Hologic demonstrates how the low dose Discovery is even better with new functionality including Hip Structure Analysis and the visualization of Abdominal Aortic Calcifications (AAC), as seen in Discovery IVA scans, as an independent and strong predictor of coronary heart disease, stroke, and other forms of cardiovascular disease. Join us at the ECTS, Booth no 17, and see how Hologic is leading the way in bone health assessment.


STAND 13 & 14
Immunodiagnostic Systems (IDS)

Boldon Business Park, Boldon, Tyne and Wear, UK
Website: www.idsltd.com

Immunodiagnostic Systems (IDS) offers a range of esoteric immunoassay kits for clinical and research use. The company focuses in Bone & Mineral Metabolism and Growth Factor research, and engages in collaborative projects with researchers worldwide.
IDS is a leader in the field of Vitamin D analysis, offering both manual and automated 25(OH) Vitamin D methods, an award-winning 1,25-Dihydroxy Vitamin D RIA system, and now announces 1,25(OH)2 Vitamin D, an EIA employing the proven immunocapsule sample preparation.
IDS offers a full range of Bone & Skeletal products, including BoneTRAP® (Tartrate-Resistant Acid Phosphatase 5b), MouseTRAP™, RatTRAP™, Bone-Specific Alkaline Phosphatase (Ostase® BAP), Intact PTH, urinary DPD, RANKL & OPG for both clinical and research (animal) use.


STAND 16
Kyphon Europe

Cluster Center, Leuvensesteenweg 369/6, 1932 Zaventem, Belgium
Website: www.kyphon-eu.com

Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive therapies including Balloon Kyphoplasty, a procedure to treat Vertebral Compression Fractures.
The technique is designed to reduce and stabilise the fracture in a controlled way, to correct vertebral body deformity and to provide significant pain reduction and improve parameters contributing to Quality Of Life.
For more information, visit www.kyphon-eu.com


STAND 11
Mindways Software

3001 S lamar Blvd., Ste 302, Austin, TX 78704 USA
Website: www.qct.com

Mindways Software Inc. produces and sells bone densitometry & analysis products. Transform your CT scanner into the ultimate bone analyzer with QCT PRO. QCT PRO takes advantage of any DICOM CT scanner to produce 3-dimensional volumetric spine and DXA-equivalent hip measurements for a fraction of the price of DXA. But, density is not enough! Move beyond densitometry with BIT, Bone Investigational Toolkit, a new product that provides bone strength, structure, and geometric analysis. See it at booth 11.


STAND 6
MSD

1 Merck Drive, WS 2C-36D, Whitehouse Station, New Jersey O8889, United States
Website: www.merck.com

FOSAVANCE™ (alendrondate/colecalciferol)
FOSAVANCE is the first and only treatment that contains a weekly dose of two therapies – FOSAMAX™ (alendronate) 70 mg, the world's leading osteoporosis treatment, and Vitamin D3 (colecalciferol) 2800 IU – in a single once-weekly tablet. FOSAVANCE is manufactured by Merck, Sharp & Dohme, a leading, research-driven pharmaceutical products and services company.


STAND 19 & 20
Nordic Bioscience/Quidel

Herlev Hovedgade 207, 2730 Herlev, Denmark
Website: www.nordicbioscience.com

The strategic partners Nordic Bioscience, Denmark and Quidel, USA, are specialists in the bone & cartilage area and supply test kits like: CrossLaps CTX, CartiLaps CTXII, N-MID Osteocalcin, Metra BAP, Metra TRAP5b, Metra OPG, Osteocalcin.

Nordic Bioscience A/S is committed to the development of therapeutic compounds and diagnostic products for improved management of patients suffering from diseases affecting bone and cartilage, such as osteoporosis, osteoarthritis, rheumatoid arthritis and bone metastasis. The focus areas are promotion of existing diagnostic products, drug discovery, drug development and development of biochemical markers. The Quidel Specialty Products Group (METRA) identifies, develops, manufactures and markets unique diagnostic and research assays kits and reagents with applications in oncology, bone health and inflammatory diseases.


STAND 1
Novartis

Lichtstrasse 35, CH-4056 Basel, Switzerland
Website: www.novartis.com

The Novartis Pharmaceuticals Division is a world leader in the discovery, development, manufacture, and marketing of prescription medicine. Our goal is to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around the world.

In 2006, the Pharmaceutical's business posted sales of USD 22.6 billion. Our current product portfolio includes more than 40 key marketed products, many of which are leaders in their respective therapeutic areas. The Development portfolio involves over 130 projects - including potential new products as well as potential new indications or formulations for existing products - in various stages of clinical development.

An important area of focus are bone disorders like osteoporosis, a progressive disease that causes bones to become thin and porous, increasing the risk for fractures. The most advanced compound in development for bone disorders is Aclasta, which was approved for the treatment of Paget’s disease in the EU in 2005 and is in development for osteoporosis.


STAND L2
Pharma-Vinci

Undalsvej 4-6, 3300 Frederiksværk
Website: www.pharma-vinci.com

Pharma-Vinci A/S is a Danish based pharmaceutical company situated in North Zealand specialised in probiotic – and VMS products for OTC and selfmedication products all licensed to domestic and export markets.

Main focus on calcium and vitamin-D based UniKalk – market leading calcium brand in Denmark and hospitals calcium drug of choice, tailored for all needs and recommendation of calcium and vitamin-D with a variety of more than 10 different compositions. All well proven and clinical documented as a beneficial drug in treatment of osteoporosis.


STAND 4
Nycomed

Langebjerg 1, DK-4000 Roskilde, Denmark
Website: www.nycomed.com

Nycomed, with corporate headquarters in Zurich, Switzerland, provides products around the world in a selected number of therapeutic areas.
Company mission is to bring medicines, like Preotact® and Calcichew® D3, that make a real difference to both patients and healthcare providers.
Preotact® is approved for the treatment of osteoporosis in post-menopausal women at high risk of fractures. It’s taken as a daily injection with a pen specially designed for osteoporosis patients. Calcichew® D3 is a chewable tablet approved for the prevention and treatment of calcium and vitamin D deficiency and as adjunct treatment of osteoporosis. It comes in a wide range of strengths and flavours.


STAND 2
Roche/GSK

Website: www.roche.com / www.gsk.com

In December 2001, Roche and GSK announced that they would co-develop and co-promote ibandronate for the treatment and prevention of postmenopausal osteoporosis in all major countries, except Japan. The Roche/GSK collaboration provides expertise and commitment to bring to market new, innovative, convenient osteoporosis therapies, designed with the patient in mind.

About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups of pharmaceuticals and diagnostics and contributes on a broad range of fronts to improving people’s health and quality of life.

About GSK
GSK, one of the world's leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.


STAND 5
Servier

22 rue Garnier - 92 200 Neuilly-sur-Seine, France
Website: www.servier.com

Servier is a leading French pharmaceutical company, involved in research and development of ethical pharmaceuticals. For several decades, the company has been expanding internationally and is now present in 140 countries.

Servier’s main areas of therapeutic research are: cardiovascular, metabolic diseases such as diabetes, neuropsychiatric diseases, cancer, and osteoporosis.

Servier discovered and developed strontium ranelate, a new treatment, licensed across Europe and in many other countries for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures. It is the first dual acting treatment, which simultaneously increases bone formation and decreases bone resorption, rebalancing bone turnover in favor of formation.


STAND 12
Skyscan NV

Kartuizersweg 3B - 2550 Kontich - Belgium
Website: www.skyscan.be

SkyScan develops state of the art micro-CT systems for high-resolution imaging, in-vivo as well as in-vitro. Software is provided for morphological characterization of bone architecture, including all typical 2D and 3D parameters such as BV/TV, TbTh, TbSp, TbN, SMI… This package can also perform density measurements using calibration phantoms. Application support can be provided by SkyScan's own bone scientists. The SkyScan 1076 allows a bone researcher to investigate trabecular structure in-vivo with pixel resolutions better than 10 micron. Our desktop instruments reach resolutions in the micron range. Now Skyscan also has a Nano-CT instrument available with a resolution better than 200 nanometers.


STAND 15
Stratec Medizintechnik

Durlacher Str. 35, 75172 Pforzheim, Germany
Website: www.stratec-med.com

Stratec Medizintechnik is the world´s most successful producer of pQCT-based bone densitometry scanner for clinical and preclinical applications. These systems offer more than conventional 2-dimensional bone densitometry. Results are presented in real density units (g/cm³). Unlike in 2-dimensional absorptiometric machines pQCT derived density measures are independent of bone size. Thereore pQCT can be applied to all age groups and body sizes. Additionaly geometrical properties of bone can be analysed which enables the user to estimate non-invasively bone´s mechanical properties. The combined analysis of muscle and bone parameters allows a detailed diagnosis and the differentiation of disuse osteopenia from true osteoporosis.


STAND 12A
XRadia

Website: www.xradia.com

Xradia is a global leader in innovative high resolution micro and nanoCTs, (resolution: mm to sub 30 nm). Featuring novel high contrast optics, 3D imaging of bone, soft tissue or biocomposites is done without contrast agents. Other products include surface and subsurface micro-elemental analysis for bone and soft tissue mineral distribution.

 

 

 

 

NEWS

 

Exhibitors

Book now!

Exhibition details

Sponsors, Exhibitors
and Other Supporters

 

 

Abstracts

Details here

Award Winners
 

 

Registration

Register here
 

 

Accommodation

Details here
 

 

Go to top